Ropivacaine 0.2% Injectable Solution: clinical trials recruiting now

Phase breakdown

Conditions being studied

Recruiting trials involving Ropivacaine 0.2% Injectable Solution

• Dexamethasone vs Dexmedetomidine for iPACK + ACB in TKA
  NCT07386600 · Phase: Not applicable (e.g. observational or device study) · Ages: 65 Years to 100 Years · Sex: All (male and female) · 1 location
• PENG Block With Dexmedetomidine in Older Adults
  NCT07327372 · Phase: Not applicable (e.g. observational or device study) · Ages: 65 Years to 100 Years · Sex: All (male and female) · 1 location
• PENG vs L-ESPB With S-ESPB for Analgesia in Total Hip Arthroplasty
  NCT07180979 · Phase: Phase 4 · Ages: 65 Years to 100 Years · Sex: All (male and female) · 1 location
• SII Levels Following PENG Block in Hip Arthroplasty
  NCT07449403 · Phase: Not applicable (e.g. observational or device study) · Ages: 65 Years to 100 Years · Sex: All (male and female) · 1 location
• Three Variants of the PENG Block With and Without Perineural Adjuvants in Older Adults
  NCT07330999 · Phase: Not applicable (e.g. observational or device study) · Ages: 65 Years to 100 Years · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve Ropivacaine 0.2% Injectable Solution?

5 recruiting trials across 6 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.